Sysmex Corporation
Research Sysmex Corporation (0YX) on Bullrun: market cap EUR 5.95B, dividend yield 2.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0YX
- ExchangeF
- CountryJapan
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 5.95B
- Dividend yield2.1%
- Financial periodFY2026
- RevenueJPY 500.01B
- Revenue growth-1.7%
- Net incomeJPY 35.46B
- Free cash flowJPY 22.88B
- Gross margin51.1%
Valuation Snapshot
latest market cap is EUR 5.95B; dividend yield is 2.1%.
Peer valuation comparison
Latest dividend yield is 2.08% versus a Healthcare sector median of 2.11%.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 500.01B | JPY 35.46B | JPY 22.88B | 51.1% | n/a | JPY 84.12B | JPY 70.48B | JPY 505.00B |
| FY2025 | JPY 508.64B | JPY 53.67B | JPY 38.29B | 53.5% | 86.05 | JPY 89.57B | JPY 64.74B | JPY 463.78B |
| FY2024 | JPY 461.51B | JPY 49.64B | JPY 13.71B | 52.5% | 79.24 | JPY 75.51B | JPY 55.34B | JPY 432.05B |
| FY2023 | JPY 410.50B | JPY 45.78B | JPY 26.33B | 52.6% | 72.91 | JPY 69.46B | JPY 22.59B | JPY 387.67B |
| FY2022 | JPY 363.78B | JPY 44.09B | JPY 26.71B | 52.4% | 70.16 | JPY 73.75B | JPY 22.28B | JPY 348.30B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-15 | EUR 5.95B | n/a | n/a | n/a |
Dividend history
Latest trailing dividend snapshot: yield 2.1%.
| Year | Dividends/share |
|---|---|
| FY2026 | 0.1 JPY |
| FY2025 | 0.2 JPY |
| FY2024 | 0.16 JPY |
| FY2023 | 0.15 JPY |
| FY2022 | 0.14 JPY |
About Sysmex Corporation
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sysmex Corporation's market cap?
Sysmex Corporation's market capitalization is EUR 5.95B.
Does Sysmex Corporation pay a dividend?
Sysmex Corporation has a dividend yield of 2.1%.
What does Sysmex Corporation do?
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software.